Trial Profile
A phase I trial of revamilast in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2009
Price :
$35
*
At a glance
- Drugs Revamilast (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Inflammation; Multiple sclerosis; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Glenmark Pharmaceuticals Ltd
- 22 Feb 2008 New trial record.